| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2019-08-09 |
详情>>
股本变动：
变动后总股本20813.74万股
|
| 2019-08-09 |
详情>>
业绩披露：
2019年中报每股收益-0.11美元,归母净利润-2234.6万美元,同比去年增长14.29%
|
| 2019-08-08 |
财报披露：
美东时间 2019-08-08 盘前发布财报
|
| 2019-05-08 |
详情>>
业绩披露：
2019年一季报每股收益-0.05美元,归母净利润-1042.4万美元,同比去年增长32.36%
|
| 2019-03-29 |
股东大会：
将于2019-05-03召开股东大会
会议内容 ▼▲
- 1.To elect two nominees to serve as the Company’s Class III Directors to hold office for a three-year term or until their respective successors are elected and qualified.
2.To approve, by an advisory vote, the compensation of our named executive officers, as disclosed in this Proxy Statement.
3.To ratify the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019.
4.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2019-03-18 |
详情>>
业绩披露：
2018年年报每股收益-0.22美元,归母净利润-4264.3万美元,同比去年增长-24.97%
|
| 2018-11-07 |
详情>>
业绩披露：
2018年三季报(累计)每股收益-0.18美元,归母净利润-3442.6万美元,同比去年增长-31.64%
|
| 2018-08-08 |
详情>>
业绩披露：
2018年中报每股收益-0.14美元,归母净利润-2607.3万美元,同比去年增长-42.48%
|
| 2018-07-09 |
详情>>
内部人交易：
Braunstein Douglas L等共交易3笔
|
| 2018-05-15 |
详情>>
业绩披露：
2018年一季报每股收益-0.08美元,归母净利润-1541.1万美元,同比去年增长-55.9%
|
| 2018-04-26 |
股东大会：
将于2018-05-31召开股东大会
会议内容 ▼▲
- 1.To elect three nominees to serve as the Company’s Class II Directors to hold office for a three-year term or until their respective successors are elected and qualified.
2.To approve, as required by and in accordance with the listing rules of NYSE American (which requires stockholder approval of a transaction other than a public offering involving the sale, issuance or potential issuance by a company of common stock (or securities convertible into or exercisable for common stock) at a price less than the greater of book or market value (i) which together with sales by officers, directors or principal shareholders of the issuer equals 20% or more of presently outstanding stock or (ii) equal to 20% or more of presently outstanding stock), the potential issuance of more than 37,565,800 shares of our common stock upon the conversion of shares of our Series A Convertible Preferred Stock, shares of our Series A-1 Convertible Preferred Stock issuable as dividends on the Series A Convertible Preferred Stock and Warrants to purchase our common stock, all of which were issued or are issuable pursuant to or in connection with the Company’s private placement that closed on March 16, 2018 (the “Private Placement Proposal”).
3.To approve an amendment to the Company’s Certificate of Incorporation to increase the number of authorized shares of common stock from 250,000,000 shares to 350,000,000 shares.
4.To approve the Company’s 2018 Stock Award Plan.
5.To approve, by an advisory vote, the compensation of our Named Executive Officers, as disclosed in this proxy statement.
6.To recommend, by an advisory vote, the frequency of future advisory votes on the compensation of our Named Executive officers.
7.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018.
8.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2018-03-19 |
详情>>
业绩披露：
2017年年报每股收益-0.2美元,归母净利润-3412.3万美元,同比去年增长-3.16%
|
| 2018-03-19 |
详情>>
业绩披露：
2016年年报每股收益-0.28美元,归母净利润-3307.8万美元,同比去年增长-15%
|
| 2017-11-08 |
详情>>
业绩披露：
2017年三季报(累计)每股收益-0.15美元,归母净利润-2615.2万美元,同比去年增长-12.3%
|
| 2017-08-09 |
详情>>
业绩披露：
2017年中报每股收益-0.11美元,归母净利润-1829.9万美元,同比去年增长-20.22%
|
| 2017-05-18 |
股东大会：
将于2017-06-22召开股东大会
会议内容 ▼▲
- Election of Class I Directors
1. To elect two nominees to serve as the Company’s Class I directors to hold office for a three-year term or until their respective successors are elected and qualified.
Amendment to the Company’s Amended and Restated 2014 Stock Award Plan
2. To approve an amendment to the Company’s Amended and Restated 2014 Stock Award Plan to increase the number of shares authorized for issuance thereunder from 18,661,856 shares to 22,700,000 shares.
Ratification of the Company’s Independent Registered Public Accounting Firm
3. To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2017.
Other Business
4. To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2016-05-13 |
股东大会：
将于2016-06-23召开股东大会
会议内容 ▼▲
- 1.To authorize the reincorporation of the Company from the State of Nevada to the State of Delaware pursuant to a plan of conversion in accordance with Nevada and Delaware law.
2.To establish a classified Board of Directors.
3.To prohibit stockholder action by written consent, effectively requiring that all stockholder actions be taken only at an annual or special meeting of stockholders.
4.To require a super-majority vote of the Company’s stockholders to take certain actions affecting the governance of the Company.
5.To elect eight directors to hold office for one-, two- or, three-year terms, as described in Proposal 2 of the Proxy Statement, if Proposals 1 and 2 are approved, or until the next annual meeting, if either Proposals 1 or 2 are not approved, and in either case until their respective successors are elected and qualified.
6.To approve an amendment and restatement of the Company’s 2014 Stock Award Plan to address certain requirements under Section 162(m) of the Internal Revenue Code, including (1) establishing a per person cap of 8,000,000 shares underlying awards that may be granted to any one individual in any one year and (2) revising the performance-based criteria intended to qualify for tax deductions under Section 162(m) of the Internal Revenue Code.
7.To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2016.
8.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|